Please login to the form below

Not currently logged in
Email:
Password:

medicines access

This page shows the latest medicines access news and features for those working in and with pharma, biotech and healthcare.

UK clears NHS use of Gilead’s remdesivir for COVID-19 patients

UK clears NHS use of Gilead’s remdesivir for COVID-19 patients

The UK medicines regulator has cleared early access to Gilead Sciences’ coronavirus drug remdesivir for people hospitalised with severe coronavirus infection, although supplies will initially be limited. ... The Medicines and Healthcare products

Latest news

More from news
Approximately 4 fully matching, plus 439 partially matching documents found.

Latest Intelligence

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    The access landscape is further complicated because many health technology assessment (HTA) methodologies are currently not geared up to evaluate these treatments. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.

  • BRIC markets BRIC markets

    The list enables the government to negotiate lower prices for medicines on the list in return for greater access to patients. ... Market access. Access strategies are also evolving. Initially multinational pharmaceutical companies entered BRIC markets by

  • Case study: Leading by example Case study: Leading by example

    The situation was compounded by a series of communications challenges. Media and political commentary highlighted the potential threats to the supply of life-saving medicines to the UK. ... Finally, the company has supported industry’s moves to

  • As the opioid crisis grabs the headlines, the search for safe treatments continues As the opioid crisis grabs the headlines, the search for safe treatments continues

    Indivior’s Gilles Picard charts a path to greater patient access and new therapies. ... But access to safer medicines has shown you can reduce mortality, HIV infection and relapse while also limiting misuse to a low percentage.

  • Evolution or revolution: the latest review of NICE methods Evolution or revolution: the latest review of NICE methods

    on Access to Medicines and Medical Devices evidence sessions on the NICE methods review inquiry. ... Leela worked as an advisor to the Department of Health and Social Care on the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).

More from intelligence
Approximately 0 fully matching, plus 92 partially matching documents found.

Latest appointments

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... During his time at Pfizer, Maine also

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country. ... She will also collaborate with the operations and patient access team to ensure the medicines are accessible to as many appropriate

  • Inceptua Medicines Access appoints senior new-hires Inceptua Medicines Access appoints senior new-hires

    Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project manager, a role that will see her focus on design and implementation of medicines access

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    As a company, Sandoz has an exciting portfolio of medicines and future product pipeline. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... He also brings experience form Boehringer Ingelheim, where he

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • New opportunities in emerging markets

    This growth is set to continue. In parallel, we are seeing an increased focus among emerging market governments on public healthcare reform: expanding their populations’ access to medicines by establishing universal ... Greater purchasing power and

  • Enabling market access through outcomes-based pricing

    Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines. ... In some cases focus on cost containment can compromise

  • The growing clinical importance of patient-reported outcomes (PROs)

    The characteristics of a well-developed PRO. Both the FDA and the European Medicines Agency (EMA) are showing interest in including PROs in their assessments. ... Soon, PRO instruments will help ensure the right patients can access medicines offering the

  • The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments

    On 9 July 2019, the World Health Organization (WHO) published the 21st edition of the EML, recommending the inclusion of 28 new medicines. ... The inclusion of innovative medicines in the WHO EML is an important step to help patients gain access to

  • Accession Accession

    Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices.

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

The big issue
Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites
Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients
A holistic view of how to work with patients virtually...

Infographics